# Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers

> **NCT02117245** · — · COMPLETED · sponsor: **Mirati Therapeutics Inc.** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02117245
- **Lead sponsor:** Mirati Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117245, "Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02117245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*